215
Views
16
CrossRef citations to date
0
Altmetric
Original Research

A comparison of long-term post-thymectomy outcome of anti-AChR-positive, anti-AChR-negative and anti-MuSK-positive patients with non-thymomatous myasthenia gravis

, MD PhD FACS, , , , &
Pages 1-8 | Published online: 12 Nov 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Rozen Le Panse, Jacky Bismuth, Géraldine Cizeron-Clairac, Julia Miriam Weiss, Perrine Cufi, Philippe Dartevelle, Nicole Kerlero De Rosbo & Sonia Berrih-Aknin. (2010) Thymic remodeling associated with hyperplasia in myasthenia gravis. Autoimmunity 43:5-6, pages 401-412.
Read now

Articles from other publishers (15)

Ikjae Lee & Gil I. Wolfe. 2021. Neurotherapeutics in the Era of Translational Medicine. Neurotherapeutics in the Era of Translational Medicine 243 264 .
Carla D. Zingariello, Melissa E. Elder & Peter B. Kang. (2020) Rituximab as Adjunct Maintenance Therapy for Refractory Juvenile Myasthenia Gravis. Pediatric Neurology 111, pages 40-43.
Crossref
Lucia S. Borges & David P. Richman. (2020) Muscle-Specific Kinase Myasthenia Gravis. Frontiers in Immunology 11.
Crossref
Konstantinos Lazaridis, Vasiliki Baltatzidou, Nikolaos Tektonidis & Socrates J. Tzartos. (2020) Antigen-specific immunoadsorption of MuSK autoantibodies as a treatment of MuSK-induced experimental autoimmune myasthenia gravis. Journal of Neuroimmunology 339, pages 577136.
Crossref
Anthony Behin & Rozen Le Panse. (2018) New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis. Journal of Neuromuscular Diseases 5:3, pages 265-277.
Crossref
Michael H. Rivner, Mamatha Pasnoor, Mazen M. Dimachkie, Richard J. Barohn & Lin Mei. (2018) Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies. Neurologic Clinics 36:2, pages 293-310.
Crossref
Marieke Robinet, Solène Maillard, Mélanie A. Cron, Sonia Berrih-Aknin & Rozen Le Panse. (2016) Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models. Clinical Reviews in Allergy & Immunology 52:1, pages 133-147.
Crossref
Tanel Punga, Rozen Panse, Mats Andersson, Frédérique Truffault, Sonia Berrih‐Aknin & Anna R. Punga. (2013) Circulating mi RNA s in myasthenia gravis: miR‐150‐5p as a new potential biomarker . Annals of Clinical and Translational Neurology 1:1, pages 49-58.
Crossref
GZ Huang & YL Lo. (2013) Correlation Between Acetylcholine Receptor Antibody Levels and Thymic Pathology in Myasthenia Gravis. Journal of Clinical Neuromuscular Disease 14:4, pages 209-217.
Crossref
David P. Richman, Kayoko Nishi, Michael J. Ferns, Joachim Schnier, Peter Pytel, Ricardo A. Maselli & Mark A. Agius. (2012) Animal models of antimuscle-specific kinase myasthenia. Annals of the New York Academy of Sciences 1274:1, pages 140-147.
Crossref
J. Calvino, M. Adeva & M.-J. Sobrido. (2012) Membranous nephropathy, leiomyoma and autoimmune myasthenia: more than a coincidence?. Clinical Kidney Journal 5:6, pages 562-565.
Crossref
Srikanth Muppidi, Gil I. Wolfe & Richard J. Barohn. 2012. Swaiman's Pediatric Neurology. Swaiman's Pediatric Neurology 1549 1569 .
Jee Young KimKee Duk ParkDavid P. Richman. (2011) Treatment of Myasthenia Gravis Based on Its Immunopathogenesis. Journal of Clinical Neurology 7:4, pages 173.
Crossref
Steven H. Abman & Michael A. Matthay. (2009) Mesenchymal Stem Cells for the Prevention of Bronchopulmonary Dysplasia. American Journal of Respiratory and Critical Care Medicine 180:11, pages 1039-1041.
Crossref
Christos Prokakis, Efstratios Koletsis, Stavroula Salakou, Efstratios Apostolakis, Nikolaos Baltayiannis, Antonios Chatzimichalis, Theodoros Papapetropoulos & Dimitrios Dougenis. (2009) Modified Maximal Thymectomy for Myasthenia Gravis: Effect of Maximal Resection on Late Neurologic Outcome and Predictors of Disease Remission. The Annals of Thoracic Surgery 88:5, pages 1638-1645.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.